TCR engineered T cells for solid tumor immunotherapy

T cell immunotherapy remains an attractive approach for cancer immunotherapy. T cell immunotherapy mainly employs chimeric antigen receptor (CAR)- and T cell receptor (TCR)-engineered T cells. CAR-T cell therapy has been an essential breakthrough in treating hematological malignancies. TCR-T cells c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yikai, Liu, Zhipeng, Wei, Wei, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210724/
https://www.ncbi.nlm.nih.gov/pubmed/35725570
http://dx.doi.org/10.1186/s40164-022-00291-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210724/
https://www.ncbi.nlm.nih.gov/pubmed/35725570
http://dx.doi.org/10.1186/s40164-022-00291-0

Ejemplares similares